P uumala virus (PUUV) belongs to the genus Hantavirus within the family Bunyaviridae, comprising typically rodent-and insectivore-borne negative-stranded RNA viruses (1). The known reservoir hosts of hantaviruses are chronically infected and spread the virus via excreta (saliva, urine, and feces) (2). The human infection, acquired via inhalation of aerosolized rodent excreta, manifests as two disease entities: hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). HFRS predominates in Eurasia, and HCPS occurs in the Americas. The case fatality rate of HFRS is 0.1 to 12%, depending on the virus type, and that of HCPS is up to 40% (3).
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Annually, around 50,000 hospitalizations due to HFRS occur in Eurasia, while a total of ϳ3,500 HCPS cases have been recorded since 1993 (4) . In Europe, the most common cause of HFRS (up to 10,000 cases per annum) is PUUV that circulates in bank voles (Myodes glareolus) (5) . The symptoms of PUUV infection, nephropathia epidemica (NE, a mild form of HFRS), include abrupt fever, followed by headache, nausea, vomiting, abdominal pain, and signs of renal insufficiency; somnolence and visual disturbances are common, and pulmonary, cardiac, and central nervous system symptoms have also been recorded. The incubation period is 2 to 6 weeks (5) (6) (7) (8) . Hantavirus infection induces a strong humoral IgM and IgG antibody response against the structural proteins, particularly the nucleocapsid (N) protein in the acute phase. Laboratory diagnosis of hantavirus disease is based on the detection of IgM and IgG antibodies, usually by immunochromatography (IgM), enzyme immunoassay (EIA) with recombinant N as the antigen, or immunofluorescence assay (IFA) based on acetone-fixed infected cells (9) (10) (11) .
Förster resonance energy transfer (FRET) has been applied widely in biomedical research (12) (13) (14) (15) (16) (17) (18) (19) , and our goal is to harness the phenomenon for infectious disease serodiagnostics. In FRET, an excited donor fluorophore transfers its energy to an acceptor fluorophore in close proximity (Ͻ10 nm). Time-resolved FRET (TR-FRET) utilizes the long fluorescence emission half-lives of lanthanides and enables background-free measurement from biological materials. We recently introduced two different principles utilizing TR-FRET for antibody detection. The first approach is based on binding of an immunoglobulin molecule to its antigens labeled distinctly with donor and acceptor fluorophores, giving rise to a FRET signal in a homogenous (wash-free) assay format (12) . The second approach is based on binding of an immunoglobulin molecule to its antigen and protein L (a bacterial protein targeting the Ig kappa light chain) labeled distinctly with fluorophores forming a FRET pair (20) . The emitted TR-FRET signal is proportional to the amount of specific immunoglobulin. Here, using recombinant full-length N protein of PUUV (PUUV-N), we showed that the protein L-based homogenous assay, referred to as LFRET, is applicable to serodiagnosis of acute Puumala virus infection.
MATERIALS AND METHODS
Clinical samples and ethical statement. We studied 211 serum samples, all of which had been sent to Helsinki University Central Hospital Laboratory Service (HUSLAB, Department of Virology and Immunology, Zoonosis Unit, Helsinki, Finland) for PUUV IgM and IgG analysis for suspicion of PUUV infection. This study was done under HUSLAB's research permission (granted by the ethics committee on 14 June 2013).
Proteins. Recombinant protein L (Thermo Scientific, Pierce Protein Biology Products) was labeled with AlexaFluor 647 (AF647) as described previously (20) . Baculovirus-expressed PUUV-N (21) was purchased from Reagena Ltd. and was labeled with europium (Eu) using the QuickAIIAssay Eu-chelated protein labeling kit (BN Products & Services Oy) according to the manufacturer's instructions. IgG CH1-binding protein was obtained from Life Technologies (Thermo Scientific) and labeled with AF647 similarly to protein L. IgG-free bovine serum albumin (BSA) was from Jackson ImmunoResearch Inc.
TR-FRET assay. A schematic illustration of the LFRET setup is presented in Fig. 1 . After dilution of the assay components in Tris-buffered saline (TBS; 50 mM Tris-HCl, 150 mM NaCl [pH 7.4]) supplemented with 0.2% BSA (TBS-BSA), protein L was mixed with the antigen, 15 l of the mixture was dispensed onto a 384-well microplate (ProxiPlate-384 Plus F; black 384-shallow-well microplate from PerkinElmer), and 5 l of serum dilution was added. After 30 min at 37°C, the TR-FRET values were measured with Wallac Victor 2 fluorometer (PerkinElmer). The values were normalized as described previously (12) . All experiments were performed in duplicate.
The assay component concentrations were optimized by a cross-titration series as described previously (20) . Since the majority (Ͼ95%) of Igs in serum are not involved in recognition of any particular microbe, an excess of protein L is required for the LFRET to function. In preliminary experiments we observed that if protein L was labeled with the acceptor fluorophore and provided in excess, the background did not notably increase. Eventually, protein L and PUUV-N were used at 25 nM and 5 nM, respectively. The optimal serum dilution was observed to be 1/100. The results were expressed as times over background (the average of normalized TR-FRET value divided by the average of normalized TR-FRET value from the negative control, a pool of PUUV-negative control sera), and the test values were reported as integers.
Reference methods. The PUUV IgM and IgG reference tests were those of HUSLAB (Department of Virology and Immunology), have been in use for 2 decades, and are accredited (SFS-EN ISO/IEC 17025 and SFS-EN ISO 15189; Finnish Standards Association). The IgM test is an IgM capture enzyme immunoassay based on recombinant PUUV-N produced in the baculovirus system similarly to the antigen we use in the LFRET assay (21) . The IgG test is an in-house immunofluorescence assay (IFA) based on PUUV-infected acetone-fixed Vero E6 cells (9, 10, 21 CH1-b assay. Protein L targets the light chain and recognizes ϳ50% of Ig molecules of nearly all isotypes. Therefore, we tested whether protein L could be replaced by AF647-labeled IgG CH1-binding protein (CH1-b), specific for human IgG. After the optimal assay parameters had been defined, the experiments with CH1-b were performed similarly to those with protein L by employing CH1-b at 25 nM, PUUV-N at 5 nM, and a serum dilution of 1/800 (on plate).
IgG depletion. To clarify the role of other Igs (mainly IgM and IgA) in the generation of the TR-FRET signal in PUUV-LFRET, we depleted the serum samples of IgG using GullSORB (Meridian Bioscience, Inc.). Each serum was diluted 1/10 (5 l serum and 45 l GullSORB) in GullSORB, and the mixture was centrifuged at a relative centrifugal force (RCF) of 16,000 for 10 s to remove IgG precipitates that might interfere with the assay. The supernatant was further diluted to yield a final dilution of 1/100. Altogether, 61 acute-infection and 27 past-infection samples were studied in this manner (by IgG depletion), as well as 7 negative samples, which had initially given false-positive results in blind testing.
Statistical analyses. The statistical analyses were performed using IBM SPSS software version 21. Boxplot analysis was used to graphically illustrate the background-corrected TR-FRET signal differences between groups.
RESULTS
Proof of concept for PUUV-LFRET for detection of antibodies in serum samples. To test whether the recently introduced LFRET assay (20) is suitable for detection of pathogen-specific antibodies in human sera, we used PUUV as a model and analyzed a panel of 58 well-defined serum samples (acute infection, n ϭ 21; past infection, n ϭ 17; negative, n ϭ 20) using Eu-labeled PUUV-N as the antigen. As a result, 20/21 acute-infection (IgG ϩ IgM ϩ ) samples induced TR-FRET signals Ն3-fold higher than the background, while all seronegative (IgG Ϫ IgM Ϫ ) samples induced signals Ͻ3-fold higher than the background (Fig. 2 
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Ϫ ) samples induced signals Ն3-fold higher than the background. Based on these results, the threshold was set at a signal level 3-fold over the background (the average plus 5.79 times the standard deviation for signals induced by the negative samples). 
Prospective testing of suspected PUUV infection samples.
After adjusting the PUUV-LFRET parameters and using a level 3-fold higher than the background as the cutoff, we examined on a daily basis blinded samples of serum from 153 patients. These samples had been sent by clinicians for IgM and IgG testing due to suspicion of PUUV infection. Typically, higher TR-FRET values were obtained with acute-phase samples than with negative or past-infection samples (Fig. 3) . Signal levels Ն3-fold over background were recorded for 39/40 acute-infection and 4/10 pastinfection samples, while a false-positive result was obtained for 7/103 PUUV-negative samples (Table 2 ). These data correspond to 97.5% sensitivity and 90.2% specificity for the PUUV-LFRET test for diagnosing acute PUUV infection. The results of both sample sets are summarized in Table 3 .
IgG CH1-binding protein.
Since protein L binds all Igs bearing the light chain, we explored the possibility of using an IgGspecific ligand to obtain the FRET signals solely from IgG. For this purpose, we set up a TR-FRET assay wherein protein L is replaced by the IgG CH1-binding protein CH1-b. Using this assay, we recorded the signals induced by the PUUV acute-and past-infection samples. All of the acute-infection samples induced lower TR-FRET signals in the CH1-b assay than in the PUUV-LFRET assay. In contrast, the TR-FRET signals induced by past-infection samples were comparable in both assays (Fig. 4) .
Removal of IgG enables specific serodiagnosis of acute PUUV infection. As shown in Fig. 3 , the TR-FRET signals induced by acute-phase PUUV infection samples were in general higher than those of past-infection samples. This prompted us to study whether the observed difference in TR-FRET responses would be due to antibodies of a class other than IgG. We applied the GullSORB reagent to remove IgGs from both acuteand past-infection samples. After this procedure, 58/61 acuteinfection samples remained positive in the PUUV-LFRET assay (value Ն 3), in contrast to none (0/10) of the past-infection samples. We next examined whether the IgG removal would affect the rate of false-positive results, and indeed, all 7 samples from seronegative individuals turned negative. Altogether, by IgG removal, acute PUUV infection was diagnosed by PUUV-LFRET with 100% specificity and 95.1% sensitivity. We counted the (Pearson) correlation of the reference enzyme-linked immunosorbent assay (ELISA) IgM absorbance values (measured at a dilution of 1:200) with the signal-to-noise ratios of the acute-phase samples from test panel 2 (after IgG depletion; n ϭ 40). The correlation coefficient was 0.19 (P ϭ 0.24, i.e., nonsignificant); however, when one outlier with an exceptional signal-to-noise ratio of 24 was ignored, the Pearson correlation (r) was 0.35 and statistically significant (P ϭ 0.0276).
DISCUSSION
We describe the first diagnostic application of a rapid homogeneous TR-FRET-based immunoassay designated LFRET. Having previously provided proof of principle for the assay using model antigens (20) , we show here that the LFRET functions in human infectious disease diagnostics. We chose to use PUUV infection as a model, since the titers of antibody against PUUV-N protein (and hantavirus N protein in general) tend to be high (often over 10,000) (9), and because the antigens and clinical samples, which had been examined with reference methods, were readily available in our laboratory. Moreover, hantavirus disease poses a significant public health issue in Europe (including Finland), with thousands of clinical cases annually and a hospitalization rate approaching 50% (22, 23) . Here, we examined 211 serum samples collected because of suspicion of PUUV infection. Altogether, we analyzed 61 acute-and 27 past-infection samples and 123 seronegative samples, using IFA and IgM capture EIA as reference methods for antiviral IgG and IgM, respectively.
With the retrospective sample panel 1, positive results were obtained with both acute-and past-infection samples, with the former typically inducing higher signals. Including both of the two sample panels, 59/61 (97%) acute-infection samples, and 14/27 (52%) past-infection samples were LFRET positive. This suggested that Igs other than IgG could have a prominent role in signal formation. To test this hypothesis, we set up a TR-FRET assay utilizing CH1-b, a Fab ligand that resembles protein L but is IgG specific. In the latter assay, the signal intensities at all stages after infection were similar, substantiating the role of IgM in LFRET reactivity of the acute-phase samples (5) . Variation in signal intensities induced by samples was also evident in both of the cohorts (acute and past infection). This might reflect individual variation in antibody clonality; i.e., some individuals could express PUUV-N-specific antibodies containing mostly (protein L binding) and others mostly light chains (24) . We also counted the correlations of the reference ELISA IgM absorbance values with the signal-to-noise ratios of the acute-phase samples of test panel 2 after IgG depletion. When one exceptional outlier was ignored, a weak positive correlation could be observed (r ϭ 0.35) which was statistically significant (P ϭ 0.0276).
To verify the contributions of Ig classes to the LFRET signal, we depleted both the acute-and past-infection samples of IgG. Notably, GullSORB treatment has been employed widely to eliminate the effect of rheumatoid factor, which causes false-positive IgM results (25, 26) . While IgG depletion eliminated the FRET signal from all the past-infection samples and the false-positive seronegatives, 58/61 (95%) acute-phase sera remained positive (cf. 59/61 prior to GullSORB). This indicates that the TR-FRET activity in the false-positive samples was due to IgG of unknown specificity. In conclusion, with the LFRET assay, rapid serodiagnosis (30 min) of Puumala hantavirus acute infection can be performed at 100% specificity and 95.1% sensitivity with IgG-depleted samples.
In all, the results indicate that the protein L-based FRET immunoassay (LFRET) (20) is applicable to serodiagnosis of infectious diseases. This homogeneous assay appears to be highly specific, sensitive, user friendly, and faster than the reference methods (IFA, ϳ2 h, and EIA, ϳ3 h), as it requires no washing. In addition to infectious diseases, it might be applicable to diagnosis of autoimmune diseases and allergies. 
